Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3436995 | 1.00 | TRPV1 (0.43) | TRPV1ALDH1A1TSHRTP53ASAH2 | |
| SCHEMBL9881033 | 0.82 | TRPV1 (0.44) | TRPV1ALDH1A1TP53ASAH2CYP1A2 | |
| SCHEMBL2208064 | 0.82 | PPARG (0.57) | ALDH1A1CYP1A2MAPTKMT2AHSD17B10 | |
| SCHEMBL2208066 | 0.82 | PPARG (0.57) | ALDH1A1CYP1A2MAPTKMT2AHSD17B10 | |
| SCHEMBL16244201 | 0.82 | CYP1A2 (0.57) | TRPV1ALDH1A1TP53ASAH2CYP1A2 | |
| SCHEMBL3338606 | 0.82 | PPARG (0.57) | ALDH1A1CYP1A2MAPTKMT2AHSD17B10 | |
| SCHEMBL4903668 | 0.82 | CYP1A2 (0.57) | TRPV1ALDH1A1TP53ASAH2CYP1A2 | |
| SCHEMBL2206876 | 0.80 | PPARG (0.60) | ALDH1A1CYP1A2CYP3A4MAPTKMT2A | |
| SCHEMBL2206758 | 0.80 | PPARG (0.60) | ALDH1A1CYP1A2CYP3A4MAPTKMT2A | |
| SCHEMBL2208737 | 0.80 | PPARG (0.60) | ALDH1A1CYP1A2CYP3A4MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025070154-A1 | POLYAMIDE RESIN, PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT AND METHOD FOR PRODUCING SAME, AND ELECTRONIC COMPONENT | 東レ株式会社 | 2025-04-03 | — | — | WO | disclosed |
| US-20240229089-A1 | A process for enzymatic synthesis of amides from amines and carboxylic acids or esters | XP CHEMISTRIES AB (SE) | 2024-07-11 | — | — | US | disclosed |
| US-20240229089-A1 | A process for enzymatic synthesis of amides from amines and carboxylic acids or esters | XP CHEMISTRIES AB (SE) | 2024-07-11 | — | — | US | disclosed |
| EP-3336081-B1 | NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND USE OF SAID COMPOUND | MICROBIAL CHEM RES FOUND (JP) | 2019-05-01 | — | — | EP | disclosed |
| US-10202347-B2 | Compound, production method therefor, and use of said compound | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 2019-02-12 | — | — | US | disclosed |
| US-10160725-B2 | — | — | 2018-12-25 | — | — | US | disclosed |
| EP-3336081-A1 | NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND USE OF SAID COMPOUND | Microbial Chemistry Research Foundation (JP) | 2018-06-20 | — | — | EP | disclosed |
| EP-3336080-A1 | NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND USE OF SAID COMPOUND | Microbial Chemistry Research Foundation (JP) | 2018-06-20 | — | — | EP | disclosed |
| US-20180093954-A1 | NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND USE OF SAID COMPOUND | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 2018-04-05 | — | — | US | disclosed |
| EP-2963020-B1 | NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND USE OF SAID COMPOUND | MICROBIAL CHEM RES FOUND (JP) | 2017-12-27 | — | — | EP | disclosed |
| WO-2008147480-A2 | HYDROXAMIC ACID DERIVATIVES OF 3-PHENYL PROPIONIC ACIDS USEFUL AS THRAPEUTIC AGENTS FOR TREATING ANTHRAX POISONING | PANTHERA BIOPHARNA, LLC. (US) | 2008-12-04 | — | — | WO | disclosed |
| US-20080188566-A1 | Hydroxamic acid derivatives of 3-Phenyl propionic acids useful as therapeutic agents for treating anthrax poisoning | PAN THERA BIOPHARMA,LLC | 2008-08-07 | — | — | US | disclosed |
| US-20080188566-A1 | Hydroxamic acid derivatives of 3-Phenyl propionic acids useful as therapeutic agents for treating anthrax poisoning | PAN THERA BIOPHARMA,LLC | 2008-08-07 | — | — | US | disclosed |
| US-20080188566-A1 | Hydroxamic acid derivatives of 3-Phenyl propionic acids useful as therapeutic agents for treating anthrax poisoning | PAN THERA BIOPHARMA,LLC | 2008-08-07 | — | — | US | disclosed |
| US-20070293703-A1 | Preparation and purification of synthetic capsaicin | ALGORX PHARMACEUTICALS, INC. (US) | 2007-12-20 | — | — | US | disclosed |
| US-20070293703-A1 | Preparation and purification of synthetic capsaicin | ALGORX PHARMACEUTICALS, INC. (US) | 2007-12-20 | — | — | US | disclosed |
| EP-0458177-B1 | Resin molding composition for preventing gnawing damage by animals | NIPPON KAYAKU KK (JP) | 1997-07-16 | — | — | EP | disclosed |
| US-5456916-A | Preventing gnawing damage by animals | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1995-10-10 | — | — | US | disclosed |
| US-5322862-A | Microcapsule filled with capsaicine derivative added to thermoplastic resins | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1994-06-21 | — | — | US | disclosed |
| EP-0458177-A1 | Resin molding composition for preventing gnawing damage by animals | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1991-11-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10160725-B2 | — | PGC, HCCS, FABP6 | TRPV1 4070/4885ALDH1A1 3112/4885TSHR 4423/4885 |
| US-10202347-B2 | Compound, production method therefor, and use of said compound | PGC, CYP51A1, WEE1 | TRPV1 3494/4885ALDH1A1 2334/4885TSHR 3862/4885 |
| US-20070293703-A1 | Preparation and purification of synthetic capsaicin | TRPV1, TRPV5, TAC3 | TRPV1 1/4885ALDH1A1 2674/4885TSHR 4323/4885 |
| US-20180093954-A1 | NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND USE OF SAID COMPOUND | PGC, WEE1, CYP51A1 | TRPV1 3627/4885ALDH1A1 2234/4885TSHR 4133/4885 |
| US-20080188566-A1 | Hydroxamic acid derivatives of 3-Phenyl propionic acids useful as therapeutic agents for treating anthrax poisoning | ANTXR2, PAOX, AGXT | TRPV1 3399/4885ALDH1A1 517/4885TSHR 2324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.